Huadong Medicine Co., Ltd

SZSE:000963 株式レポート

時価総額：CN¥61.7b

Huadong Medicine 将来の成長

Future 基準チェック /16

Huadong Medicine利益と収益がそれぞれ年間13.2%と7.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に16.8% 13.1%なると予測されています。

主要情報

13.2%

収益成長率

13.1%

EPS成長率

Healthcare 収益成長23.0%
収益成長率7.9%
将来の株主資本利益率16.8%
アナリストカバレッジ

Good

最終更新日13 Nov 2024

今後の成長に関する最新情報

Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Apr 21
Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

Investors Aren't Buying Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Nov 13
Investors Aren't Buying Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Sep 23
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Aug 05
Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

Jun 28
Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Jun 10
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Apr 21
Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Apr 08
Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Is Huadong Medicine (SZSE:000963) A Risky Investment?

Mar 16
Is Huadong Medicine (SZSE:000963) A Risky Investment?

業績と収益の成長予測

SZSE:000963 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202650,2604,2803,2404,78612
12/31/202546,8343,9082,7214,23014
12/31/202443,2473,2922,6153,94214
9/30/202441,7073,2122,6094,186N/A
6/30/202441,2043,1012,5164,183N/A
3/31/202440,9202,9462,0103,691N/A
12/31/202340,6242,8392,3233,929N/A
9/30/202340,2512,7071,9963,311N/A
6/30/202339,9022,5922,9324,119N/A
3/31/202338,8972,5509982,396N/A
1/1/202337,7152,4991,1892,382N/A
9/30/202236,4942,3881,2662,384N/A
6/30/202235,5822,3426961,715N/A
3/31/202234,5992,2481,8972,607N/A
1/1/202234,5632,3022,3513,170N/A
9/30/202134,1102,3242,4683,616N/A
6/30/202134,2022,3892,5403,894N/A
3/31/202133,9822,4311,9863,495N/A
12/31/202033,6832,8201,9383,411N/A
9/30/202033,3192,9911,6692,994N/A
6/30/202033,8582,9481,0362,294N/A
3/31/202034,3393,0531,3452,654N/A
12/31/201935,4462,8136482,002N/A
9/30/201935,0872,6714691,537N/A
6/30/201933,5872,5708781,932N/A
3/31/201932,5322,5151,2252,163N/A
12/31/201830,6632,2671,1632,039N/A
9/30/201829,5852,0992,2152,946N/A
6/30/201829,0662,031N/A2,455N/A
3/31/201828,5191,895N/A1,985N/A
12/31/201727,8321,780N/A1,661N/A
9/30/201727,9111,740N/A1,009N/A
6/30/201727,2271,665N/A612N/A
3/31/201726,3631,556N/A1,085N/A
12/31/201625,3801,447N/A1,347N/A
9/30/201624,4911,365N/A957N/A
6/30/201623,5881,253N/A796N/A
3/31/201622,6821,188N/A387N/A
12/31/201521,7271,097N/A659N/A
9/30/201520,9231,136N/A545N/A
6/30/201520,2201,034N/A1,144N/A
3/31/201519,656899N/A857N/A
12/31/201418,947757N/A741N/A
9/30/201418,208655N/A1,349N/A
6/30/201417,724631N/A624N/A
3/31/201417,237617N/A395N/A
12/31/201316,718575N/A477N/A

アナリストによる今後の成長予測

収入対貯蓄率: 000963の予測収益成長率 (年間13.2% ) は 貯蓄率 ( 2.8% ) を上回っています。

収益対市場: 000963の収益 ( 13.2% ) CN市場 ( 26% ) よりも低い成長が予測されています。

高成長収益: 000963の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 000963の収益 ( 7.9% ) CN市場 ( 13.9% ) よりも低い成長が予測されています。

高い収益成長: 000963の収益 ( 7.9% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 000963の 自己資本利益率 は、3年後には低くなると予測されています ( 16.8 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y